Ceftazidime is a Intramuscular; Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Wg Critical Care, Llc. The primary component is Ceftazidime.
| Product ID | 44567-235_08842d2b-a211-4556-96bd-864e4c85b876 |
| NDC | 44567-235 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ceftazidime |
| Generic Name | Ceftazidime |
| Dosage Form | Injection, Powder, For Solution |
| Route of Administration | INTRAMUSCULAR; INTRAVENOUS |
| Marketing Start Date | 2013-01-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA062640 |
| Labeler Name | WG Critical Care, LLC |
| Substance Name | CEFTAZIDIME |
| Active Ingredient Strength | 1 g/20mL |
| Pharm Classes | Cephalosporin Antibacterial [EPC],Cephalosporins [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2013-01-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA062640 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2013-01-31 |
| Ingredient | Strength |
|---|---|
| CEFTAZIDIME | 1 g/20mL |
| SPL SET ID: | bcc81df2-20e3-4738-bfcf-301da883c1d9 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0781-3177 | Ceftazidime | Ceftazidime |
| 0781-3178 | Ceftazidime | Ceftazidime |
| 0781-3179 | Ceftazidime | Ceftazidime |
| 25021-127 | Ceftazidime | ceftazidime |
| 25021-128 | Ceftazidime | Ceftazidime |
| 25021-129 | Ceftazidime | Ceftazidime |
| 44567-236 | Ceftazidime | Ceftazidime |
| 44567-235 | Ceftazidime | Ceftazidime |
| 44567-237 | Ceftazidime | Ceftazidime |
| 0264-3143 | Ceftazidime and Dextrose | CEFTAZIDIME |
| 0264-3145 | Ceftazidime and Dextrose | CEFTAZIDIME |
| 0409-5082 | TAZICEF | CEFTAZIDIME |
| 0409-5084 | TAZICEF | CEFTAZIDIME |
| 0409-5086 | TAZICEF | CEFTAZIDIME |
| 0409-5092 | TAZICEF | CEFTAZIDIME |
| 0409-5093 | TAZICEF | CEFTAZIDIME |